Marijuana Stocks & Publicly Traded Cannabis Companies

GrowLife Gets $40M Funding Commitment

GrowLife, a publicly traded company that makes software and equipment for the cultivation and sale of marijuana, will receive up to $40 million in funding from a Nevada private investment group called CANX USA. California-based GrowLife said it will use the funding make acquisitions and provide financing to cultivation operations and dispensaries in eight states […]

Read More

Abattis Names New CFO, COO

Publicly traded Canadian MMJ company Abattis Bioceuticals Corp. has named real estate and finance veteran Rene David to the posts of chief financial officer and chief operating officer. The move comes as Abattis prepares for rapid growth amid drastic changes in the Canadian medical marijuana industry. The country has opened up its MMJ program to […]

Read More

MedBox Hires Investment Bank for Strategic Options

Technology and consulting company MedBox Inc. announced today it has teamed up with the Santa Monica, Calif-based investment bank DelMorgan & Co to review its strategic options. MedBox said it will explore various opportunities for raising additional capital, including joint ventures, acquisitions, divestitures and strategic alliances. It also could consider an initial public offering on […]

Read More

Week in Review: 6 Takeaways From Recent PR Ordeals + Washington Cannabis Regulations

By Chris Walsh For the second time in five months, a prominent medical marijuana company has found itself on the defensive after critical postings online set investors on edge. Earlier this week, MedBox Inc. issued a shareholder letter to rebut an investigative article painting the company and its founder in a negative light. MedBox also […]

Read More

MedBox Attempts to Assuage Shareholders After Critical Report on Founder, Company

MedBox Inc. has deemed a recent investigative report about the company’s founder as “reckless” and “deceptive,” adding that negative press is an inevitable downside of success and increased exposure. The company issued the comments – and offered new financial guidance – in a letter to shareholders, hoping to stem any damage resulting from the report. […]

Read More

Impact of DOJ Announcement, Cole Memo Short-Lived for Most Marijuana Stocks

The third quarter was surprisingly lackluster for publicly traded cannabis companies, with most stocks failing to hold gains tied to a groundbreaking move by the Department of Justice in August. Six of 12 prominent cannabis and hemp-related stocks came in flat for the July-September period, while two fell. Just four rose in value.

Read More

Regulatory Group’s Warning About Marijuana Stock Scams Highlights Difficulties MMJ Investors Face

Attention investors: If you’re thinking about pumping money into cannabis stocks, be very, very careful. That’s the advice a self-regulatory agency for brokerage firms and exchange markets issued this week. In an alert to investors, the Financial Industry Regulatory Authority (or Finra) said that con artists are increasingly setting their sights on the medical marijuana industry by […]

Read More

Earnings Update: Mixed Quarterly Results for 2 Publicly Traded Medical Cannabis Companies

Two of the more prominent – and transparent – publicly traded companies in the medical cannabis industry released second-quarter financial data this week, offering up a mixed bag for investors. GrowLife Inc. and Medical Marijuana Inc. reported financial progress in several areas but experienced setbacks in others, reflecting the challenges public MMJ companies as a […]

Read More

Medical Cannabis Stocks Socked in Second Quarter as Public Firms Fail to Gain Traction

Medical marijuana stocks continued to struggle in the second quarter despite increasing optimism over the industry’s future, underscoring the risky nature of cannabis investments and the sector itself. The share price of nearly every publicly traded company involved in the cannabis space fell or was flat from April through June – with a handful of […]

Read More

GrowLife’s Acquisition Strategy Leads to Spike in Revenues, But Wider Net Loss, in Q1

GrowLife Inc., a publicly traded company that provides cultivation equipment and related technology to the medical marijuana industry, reported a sevenfold increase in revenues during the first quarter but also sunk deeper into the red mainly due to non-cash charges. Revenues soared to $760,709 during the first three months of the year vs. $91,809 in […]

Read More